ArticleBiomedicines2026
Integrated RNA-seq and RT-qPCR Workflow Identifies Non-IGH Fusion Transcripts as Individualized Molecular Markers for Monitoring Multiple Myeloma.
Yifei Ren, Yang Lu, Dan Huang, Xuehong Zhang, Beibei Gao, Xijia Wang, Xiangjie Kui, Hongchen Liu, Jiacheng Lou, Jinsong Yan
Abstract read
In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Yifei RenDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.
Yang LuDepartment of Hematology, Chaoyang Central Hospital, Chaoyang City 122000, China.
Dan HuangDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.
Xuehong ZhangCenter of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.ORCID 0000-0001-8040-4141 Beibei GaoDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.
Xijia WangDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.
Xiangjie KuiDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.
Hongchen LiuDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.
Jiacheng LouDepartment of Pediatrics, The Second Hospital of Dalian Medical University, Dalian 116027, China.ORCID 0000-0003-3109-7266 Jinsong YanDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, The Second Hospital of Dalian Medical University, Dalian 116027, China.ORCID 0000-0003-4109-2602 Funding
the "1+X" Clinical Research Summit Project of the Liaoning Provincial Department(Jinsong Yan)) LCGF2024001the General Project of the Liaoning Provincial Department of Education(Hongchen Liu)) JYTMS20230582
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
fusion genesminimal residual diseasemolecular biomarkersmultiple myeloma
Identifiers
PMID41751254
PMCPMC12937900
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390